← Eichor
Study identifier: NCT06593392 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Condition: Pruritus · Chronic Kidney Diseases  ·  Sponsor: Vifor Fresenius Medical Care Renal Pharma

PhasePhase 2
Planned participants18
Who can joinAll sexes, 12 Years to 18 Years
Healthy volunteersNo

About this study

Rationale: * People with long term kidney disease who are on haemodialysis (a procedure for removing waste products from the blood) commonly develop a condition that makes their skin very itchy. * Difelikefalin is a medicine that can treat the itching related to long term kidney disease. * Clinical studies have shown difelikefalin to reduce itching in adults on haemodialysis, while being safe and tolerable. * The current study is being done in adolescents aged 12 to 17 years on haemodialysis who have moderate to severe itching related to long term kidney disease to assess if difelikefalin is safe in this age group. The aims of the study are: Main aim: To assess the safety of difelikefalin in adolescents who are on haemodialysis and have itching related to long term kidney disease Secondary aim: To measure the amount of difelikefalin that enters the blood in adolescents who are on haemodialysis and have itching related to long term kidney disease Study Design At least 18 adolescents, aged 12 to 17 years, who are on haemodialysis and have itching related to long term kidney disease will take part in this study. All study participants will receive difelikefalin 3 (or up to 4) times weekly for up to 12 weeks. The study duration for a participant is up to 17 to 18 weeks; during this period, participants will visit the clinic 3 times weekly (during their haemodialysis visits).

This description comes directly from the study's public registry record.

Talk to the study team

Yael Carmeli  ·  +41 058 851 80 00  ·  clinicaltrials@cslbehring.com

Always discuss trial participation with your own doctor first.

Locations (16)

Sichuan University-West China Second University HospitalChengdu, ChinaRecruiting
The First Affiliated Hospital, Sun Yat-sen UniversityGuangzhou, ChinaRecruiting
Guangzhou Women and Children's Medical CenterGuangzhou, ChinaRecruiting
The Children's Hospital Zhejiang University School of MedicineHangzhou, ChinaRecruiting
The Children's Hospital of Fudan UniversityShanghai, ChinaRecruiting
Huazhong University of Science and Technology-Tongji Medical College-The Central Hospital of WuhanWuhan, ChinaRecruiting
Pan and Aglaia Kyriakou Children's HospitalAthens, GreeceRecruiting
Shaare Zedek Medical CenterJerusalem, IsraelRecruiting
Schneider Children's Medical Center of IsraelPetah Tikva, IsraelRecruiting
King Faisal Specialist Hospital and Research Center, RiyadhRiyadh, Saudi ArabiaRecruiting
King Abdullah Specialized Children's Hospital (KASCH)Riyadh, Saudi ArabiaRecruiting
Hospital Sant Joan de DéuBarcelona, SpainRecruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06593392